Concerto HealthAI is a global leader in real-world data, AI technology, and real-world evidence services for precision oncology and dedicated to engineering integrated data and technology solutions that help achieve the best possible outcomes for patients. Founded in 2017, Concerto HealthAI is backed by investors that include Maverick Ventures, Declaration Partners, SymphonyAI, and Alliance Bernstein and is headquartered in Boston, Massachusetts.